Analysis of risk factors for in-hospital mortality in 177 patients who underwent isolated coronary bypass grafting and received intra aortic balloon pump.
coronary artery disease
coronary bypass grafting
intra aortic balloon pump
outcomes
Journal
Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
revised:
23
12
2020
received:
06
11
2020
accepted:
16
01
2021
pubmed:
20
2
2021
medline:
15
5
2021
entrez:
19
2
2021
Statut:
ppublish
Résumé
Intra-aortic balloon pump (IABP) is the most commonly used device for circulatory support of patients with heart disease. The aim of this study evaluated the risk factors for outcomes of patients who underwent isolated coronary bypass grafting and received IABP. One hundred-seventy-seven patients underwent isolated coronary bypass grafting and received intraoperative IABP. All perioperative data were recorded. The primary end-point was in-hospital mortality, while the secondary end-points were the length of intensive care unit (ICU) stay and hospital length of stay (LOS). In-hospital mortality was 5.6% (10 patients). Multivariable logistic regression analysis showed that the risk factors for in-hospital mortality were preoperative plasma creatinine level and cardiopulmonary bypass (CPB) time (for both p < .05). Multivariable linear regression analysis showed that postoperative acute kidney injury (AKI), immediate plasma troponin after operation, numbers of grafts, and CPB time were predicted the hospital LOS, while postoperative AKI, preoperative left ventricular ejection fraction, and immediate plasma troponin after operation were predicted the lengths of ICU stay. Our analysis showed that increased preoperative plasma creatinine, postoperative renal dysfunction, and CPB time negatively affected the outcomes of patients who received intraoperative IABP insertion.
Sections du résumé
BACKGROUND AND AIM OF THE STUDY
OBJECTIVE
Intra-aortic balloon pump (IABP) is the most commonly used device for circulatory support of patients with heart disease. The aim of this study evaluated the risk factors for outcomes of patients who underwent isolated coronary bypass grafting and received IABP.
METHODS
METHODS
One hundred-seventy-seven patients underwent isolated coronary bypass grafting and received intraoperative IABP. All perioperative data were recorded. The primary end-point was in-hospital mortality, while the secondary end-points were the length of intensive care unit (ICU) stay and hospital length of stay (LOS).
RESULTS
RESULTS
In-hospital mortality was 5.6% (10 patients). Multivariable logistic regression analysis showed that the risk factors for in-hospital mortality were preoperative plasma creatinine level and cardiopulmonary bypass (CPB) time (for both p < .05). Multivariable linear regression analysis showed that postoperative acute kidney injury (AKI), immediate plasma troponin after operation, numbers of grafts, and CPB time were predicted the hospital LOS, while postoperative AKI, preoperative left ventricular ejection fraction, and immediate plasma troponin after operation were predicted the lengths of ICU stay.
CONCLUSION
CONCLUSIONS
Our analysis showed that increased preoperative plasma creatinine, postoperative renal dysfunction, and CPB time negatively affected the outcomes of patients who received intraoperative IABP insertion.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1460-1465Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Smilowitz NR, Galloway AC, Ohman EM, et al. Coronary revascularization and circulatory support strategies in patients with myocardial infarction, multi-vessel coronary artery disease, and cardiogenic shock: insights from an international survey. Am Heart J. 2020;225:55-59.
Thiele H, Zeymer U, IABP-SHOCK II trial investigators, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367:1287-1296.
Ho CH, Chen ZC, Chu CC, Wang JJ, Chiang CY. Temporal trends of in-hospital mortality in patients treated with intra-aortic balloon pumping: a nationwide population study in Taiwan, 1998-2008. PLoS One. 2015;10:e0131575.
Zhang XW, Song ZG, Wang L, et al. The use of intra-aortic balloon pump in patients undergoing heart valve replacement: outcome and risk analysis. J Heart Valve Dis. 2014;23:458-462.
Joskowiak D, Szlapka M, Kappert U, Matschke K, Tugtekin SM. Intra-aortic balloon pump implantation does not affect long-term survival after isolated CABG in patients with acute myocardial infarction. Thorac Cardiovasc Surg. 2011;59:406-410.
Kapur NK, Hirst CS, Davila CD, Garcia R. Single stick access using a VA-ECMO arterial return cannula for coronary intervention in cardiogenic shock. Catheter Cardiovasc Interv. 2020. https://doi.org/10.1002/ccd.29073
Chen K, Hou J, Tang H, Hu S. Concurrent initiation of intra-aortic balloon pumping with extracorporeal membrane oxygenation reduced in-hospital mortality in postcardiotomy cardiogenic shock. Ann Intensive Care. 2019;9:16.
Akodad M, Delmas C, Bonello L, Duflos C, Roubille F. Intra-aortic balloon pump: is the technique really outdated? ESC Heart Fail. 2020;7:1025-1030.
Liu F, Yang F, Du Z, et al. Timing of intra-aortic balloon pump placement before off-pump coronary artery bypass grafting and clinical outcomes. Artif Organs. 2018;42:263-270.
Deppe AC, Weber C, Liakopoulos OJ, et al. Preoperative intra-aortic balloon pump use in high-risk patients prior to coronary artery bypass graft surgery decreases the risk for morbidity and mortality-a meta-analysis of 9,212 patients. J Card Surg. 2017;32:177-185.
Zaky SS, Hanna AH, Sakr Esa WA, et al. An 11-year, single-institution analysis of intra-aortic balloon pump use in cardiac surgery. J Cardiothorac Vasc Anesth. 2009;23:479-483.
Chang SN, Hwang JJ, Chen YS, Lin JW, Chiang FT. Clinical experience with intra-aortic balloon counterpulsation over 10 years: a retrospective cohort study of 459 patients. Resuscitation. 2008;77:316-324.
Sousa-Uva M, Neumann FJ, Ahlsson A, et al. ESC Scientific Document Group 2018 ESC/EACTS guidelines on myocardial revascularization. Eur J Cardiothorac Surg. 2019;55:4-90.
Ton VK, Xie R, Hernandez-Montfort JA, et al. Short- and long-term adverse events in patients on temporary circulatory support before durable ventricular assist device: an IMACS registry analysis. J Heart Lung Transplant. 2020;39:342-352.
Wang J, Yu W, Gao M, Gu C, Yu Y. Preoperative prophylactic intraaortic balloon pump reduces the incidence of postoperative acute kidney injury and short-term death of high-risk patients undergoing coronary artery bypass grafting: a meta-analysis of 17 studies. Ann Thorac Surg. 2016;101:2007-2019.
Babatasi G. Pre-operative balloon counterpulsation and off-pump coronary surgery for high-risk patients. Cardiovasc Surg. 2003;11:145-148.
Fujino T, Imamura T, Kinugawa K. Future perspectives of intra-aortic balloon pumping for cardiogenic shock. Int Heart J. 2020;61:424-428.
Yu PJ, Cassiere HA, Dellis SL, Kohn N, Manetta F, Hartman AR. Propensity-matched analysis of the effect of preoperative intraaortic balloon pump in coronary artery bypass grafting after recent acute myocardial infarction on postoperative outcomes. Crit Care. 2014;18:531.
Saura E, Savola J, Gunn J. A 6-year single-center experience of intra-aortic balloon pump treatment-retrospective analysis of 223 patients. J Cardiothorac Vasc Anesth. 2015;29:1410-1414.
Saha KK, Kaushal RP, Kumar A, Deval M, Saha KK, Kaul SK. Intraaortic balloon pump boon for off-pump coronary artery bypass grafting. Asian Cardiovasc Thorac Ann. 2015;23:267-270.
Kusumoto G, Shigematsu K, Iwashita K, Tominaga K, Totoki T, Yamaura K. Association between preoperative cardiac left ventricular dysfunction and perioperative intraaortic balloon pump in patients undergoing off-pump coronary artery bypass surgery. Heart Surg Forum. 2017;20:E147-E152.
Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124:e652-e735.
Lavana JD, Fraser JF, Smith SE, Drake L, Tesar P, Mullany DV. Influence of timing of intraaortic balloon placement in cardiac surgical patients. J Thorac Cardiovasc Surg. 2010;140:80-85.
Thiele H, Zeymer U, Intraaortic balloon pump in cardiogenic shock II (IABP-SHOCK II) trial investigators, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet. 2013;382:1638-1645.
He XY, Gao CQ. Peri-operative application of intra-aortic balloon pumping reduced in-hospital mortality of patients with coronary artery disease and left ventricular dysfunction. Chin Med J. 2019;132:935-942.
Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol. 2006;1:19-32.
Coca SG, Yusuf B, Shlipak MG, Garg AX, Parikh CR. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;53:961-973.
Lannemyr L, Bragadottir G, Krumbholz V, Redfors B, Sellgren J, Ricksten SE. Effects of cardiopulmonary bypass on renal perfusion, filtration, and oxygenation in patients undergoing cardiac surgery. Anesthesiology. 2017;126:205-213.
Kirmani BH, Holmes MV, Muir AD. Long-term survival and freedom from reintervention after off-pump coronary artery bypass grafting: a propensity matched study. Circulation. 2016;134:1209-1220.
Hilberman M, Derby GC, Spencer RJ, Stinson EB. Effect of the intraaortic balloon pump upon postoperative renal function in man. Crit Care Med. 1981;9:85-89.
Gamoso MG, Phillips-Bute B, Landolfo KP, Newman MF, Stafford-Smith M. Off pump vs on pump coronary artery bypass surgery and postoperative renal dysfunction. Anesth Analg. 2000;91:1080-1084.
Muniraju G, Pandey S, Chakravarthy M, Krishnamoorthy J, Narayan S, Jawali V. Intra-aortic balloon pump use does not affect the renal function in patients undergoing off pump coronary artery bypass surgery. Ann Card Anaesth. 2011;14:188-191.